Back to search

Netherlands· NL-bc8d1f8c8d78

Anoro Ellipta 55 microgram/22 microgram inhalatiepoeder, voorverdeeld

A vilanterol und umeclidinium bromid product containing umeclidiniumbromide + vilanteroltrifenataat, registered in Netherlands by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 11 of our 19 countries.

ATC R03AL03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAnoro Ellipta 55 microgram/22 microgr…ATCR03AL03REGISTER NO.NL-bc8d1f8c8d78PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Vilanterol und umeclidinium bromid is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AL03 (vilanterol und umeclidinium bromid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Vilanterol und umeclidinium bromid · ATC R03AL03

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
UMECLIDINIUMBROMIDE + VILANTEROLTRIFENATAAT
Manufacturer
GlaxoSmithKline Trading Services Limited
Country
Netherlands (NL)
ATC code
R03AL03
ATC class
Vilanterol und Umeclidinium bromid
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/14/898

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Vilanterol und umeclidinium bromid in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vilanterol und umeclidinium bromid products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Anoro Ellipta, Laventair Ellipta
  • Liechtenstein · Anoro Ellipta, Laventair Ellipta
  • Norway · Anoro Ellipta, Laventair Ellipta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/96309c1b-ccdc-493d-9dda-ba8620801b93
GET /v1/drugs/96309c1b-ccdc-493d-9dda-ba8620801b93?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Inhalatiepoeder, voorverdeeld",
  "route": "Inhalatie",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/anoro-ellipta-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Vilanterol and umeclidinium bromide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp113416",
  "excipients": [
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)"
  ],
  "substances": [
    "UMECLIDINIUMBROMIDE",
    "VILANTEROLTRIFENATAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2014/05/08",
  "procedure_number": "EMEA/H/C/002751",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/14/898",
  "additional_monitoring": "N"
}

See everything about vilanterol und umeclidinium bromid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.